The plasminogen activator inhibitor system in colon cancer cell lines is influenced by the CO2 pneumoperitoneum by Krause, Petra et al.
ORIGINAL ARTICLE
The plasminogen activator inhibitor system in colon cancer
cell lines is influenced by the CO2 pneumoperitoneum
Petra Krause & Nina S. Bobisch & Paul Thelen &
Karola Koehler & Sarah Koenig & Heinz Becker &
Ingo Leister
Accepted: 17 September 2010 /Published online: 8 October 2010
# The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract
Purpose Laparoscopic surgery in the treatment of colon
carcinoma causes pH value alterations as well as changes in
fibrinolytic activity. This results in enhanced proliferation of
colon carcinoma cells in vitro and also in enhanced growth of
liver metastasis when compared to isobaric (gasless) laparos-
copy in vivo. So far, the direct influence of CO2 pneumo-
peritoneum on the invasiveness and metastatic capabilities of
colon cancer cells remains unclear. We therefore evaluated
transcripts of the uPA system.
Methods The influence of CO2 pneumoperitoneum on the
gene expression of plasminogen activator inhibitor-1 (PAI-
1), urokinase-type plasminogen activator (uPA), and tissue-
type plasminogen activator (tPA) was investigated in colon
carcinoma cell lines (HT116, SW48, and WiDr) and
mesothelial cells employing a pneumoperitoneum chamber
in vitro. Quantitative gene expression data were collected
usingreal-timeRT-PCRandstatisticalanalysiswasperformed
by means of analysis of variance and Bonferroni correction.
Results The expression of uPA and PAI-1 was increased in
colon carcinoma cell lines when cultivated at pH 6.1, a
value corresponding to intraabdominal pH values during
CO2 insufflation. Elevated PAI-1 mRNA levels were also
observed when CO2 was simultaneously applied with a
pressure of 10 mmHg. In contrast, there were no significant
changes in mesothelial cells in the investigated parameter.
Conclusion The conditions of CO2 pneumoperitoneum
cause changes in the expression of genes controlling the
fibrinolytic activity. The increase of PAI-1 and uPA can
contribute to the enhancement of metastasis and invasive
potential of tumour cells. Therefore, changes in the
conditions of laparoscopy may well optimise laparoscopic
therapy in colon cancer.
Keywords CO2 pneumoperitoneum.Metastasis.Plasmin
activator system.Tumour cell lines
Introduction
Although there has been a steady increase in the number of
laparoscopic colorectal resections of malignant disease since
the mid-1990s, minimally invasive procedures were more
commonlyperformedforbenignconditions.Inthiscontext,the
literature refers to the increased proliferation of tumour cells in
vitro under CO2 pneumoperitoneum conditions [1]a sw e l la s
enhanced growth of liver metastases compared to isobaric
(gasless) laparoscopy in vivo [2]. Therefore, the question has
to be addressed as to whether CO2 pneumoperitoneum may
be directly or indirectly related to the enhanced invasion and
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the fibrinolytic system is involved in this process.
During surgery, the intraperitoneal fibrinolytic activity of the
plasminogen activator system plays a pivotal role in the
maintenance of intraperitoneal fibrinolysis and in the formation
of postoperative adhesions. Moreover, the urokinase plasmin-
ogen activator (uPA) system is intimately implicated in tumour
cell interaction with the extracellular matrix (ECM) and
mesothelial cells, both being essential to tumour progression.
The uPA system is based on the serine protease plasmin, their
activators tissue-type plasminogen activator (tPA) and
urokinase-type plasminogen activator (uPA), as well as the
plasminogen activator inhibitors PAI-1 and PAI-2 [3]. tPA and
uPA effect proteolysis by converting plasminogen to plasmin.
Abdominal insufflation with CO2 causes severe trauma
leading to disintegration of the peritoneal mesothelium,
which is covered by monolayer mesothelial cells. Electron
microscopic investigations revealed morphological changes
of the peritoneum under laparoscopic conditions such as
high infiltration of granulocytes [4]. Furthermore, changes
in pressure, pH shifts, or dehydration effects may also result
in functional impairment. The literature reports only few
experimental data on the evaluation of intraperitoneal
fibrinolytic activity under laparoscopic conditions. The
findings of these studies are controversial [5–8] and focus
on the peritoneum with regard to peritoneal healing and the
development of clinically relevant postoperative adhesions.
However, the effect of pneumoperitoneum on the uPA
system has severe consequences for tumour cell progres-
sion. Plasmin displays an extended substrate spectrum and
degrades fibrin as well as a large number of ECM proteins
such as fibronectin or vitronectin. In addition, plasmin
activates several metalloproteinases and these in turn
degrade ECM, a crucial requirement for activating the
metastatic cascade. Proteolysis, effective tumour cell
invasion, and metastatic dispersal depend on the balance
of the uPA system. In this context, it was recently
demonstrated that expression levels of uPA and PAI-1
correlate with the prognosis of bronchial [9], ovarian [10],
endometrial cancer [11], breast [12], gastric [13–15], and
colon carcinomas [16–24]. CO2 insufflation influences
essential cell functions of colon carcinoma cells such as
intra- and extracellular pH values, intracellular calcium
levels, and the oxygen partial pressure in the surrounding
tissue. Wildbrett et al. [25, 26] demonstrated an evident
intra- and extracellular increase in the pH value from 7.4 to
6.2 due to CO2 application leading to acidification. Small
numbers of emerging protons can be buffered, whereas
higher concentrations lower intra- and extracellular pH
values. The decrease in intracellular pH values leads to a
series of physiological changes relating to the respiratory
chain [27], mitotic activity [28], as well as the secretion of
cytokines and inflammation mediators [29]. Additionally,
the increased intracellular proton concentration influences the
calcium influx into the cell [30]. Even submicromolar
increments cause maximum stimulation of calcium-
dependent signal transduction pathways [31]. Elevated
intracellular calcium levels increase gene transcription [32],
stimulation of mitosis [33–35], as well as cell migration,
enhance transcellular ion transport, neurotransmitter release,
acid secretion, and several other cell functions [36].
Previous investigations demonstrated that mechanical
deformation of the human colon carcinoma cell line
HCT116 causes an increased expression of PAI-1 [37]. Such
a deformation of tumour cells following insufflation with
CO2 and the subsequent increase in intraabdominal pressure
during laparoscopy might be conceivable. Nevertheless,
there are no studies on the effect of pneumoperitoneum on
the expression of PAI-1 or uPA in tumour cells so far.
The aim of the present study was to evaluate the effect of
CO2 pressure and pH shifts on the expression of uPA, tPA
and PAI in colon cancer cells and mesothelial cells.
Material and methods
Materials
Unless specified otherwise, all chemicals and reagents were
supplied by Sigma–Aldrich (Deisenhofen, Germany). Petri
dishes and culture flasks were obtained from Sarstedt
(Nuremberg, Germany). Antibiotics were supplied by
PAA (Linz, Austria), and PBS (10×), HBSS (10×) and
trypsin by Invitrogen (Karlsruhe, Germany).
Tumour cell lines
Human colon carcinoma cell lines WiDr, HCT116 and
SW48 (ATCC, Manassas, USA) were routinely cultured on
gelatine-coated (0.2%) 25-cm² culture flasks in RPMI
supplemented with 10% FCS, 1% penicillin/streptomycin
at 37°C and 5% CO2 in a humidified incubator. Cells were
trypsinized when obtaining 75% confluence and distributed
to 18 Petri dishes (Ø 3.5 cm). Experiments were performed
in the pneumoperitoneum chamber when 75% confluency
was once more achieved. All colon carcinoma cell lines
were derived from primary colon tumours.
Mesothelial cells
Experiments were approved by the local ethics committee.
Human mesothelial cells were isolated from omental
adipose tissue according to the protocol of Ivarsson et al.
[38] with minor modifications. A 5×5-cm² (approx. 10 g)
tissue biopsy was washed in 50 ml HBSS, following
incubation in HBSS supplemented with 0.05% trypsin–
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flushedimmediatelywithRPMIsupplementedwith20%FCS
to neutralise enzyme activity and to aid in detachment. Cell
suspensions were centrifuged for 10 min at 260×g and
cultivated in M199 (Gibco, Eggenstein, Germany) +20%
FCS+1% penicillin/streptomycin at 37°C and 5% CO2 in a
humidified incubator. The cells were seeded on gelatine-
coated (0.2%) 25-cm² culture flasks. One week later, cells
were trypsinized and disseminated in 18 Petri dishes (Ø
3.5 cm). Experiments were performed following achieve-
ment of 75% confluent cell growth. For immunohistological
characterisation, the primary monoclonal antibodies (DAKO,
Glostrup) CK7 (clone OV-TL 12/30), CK8 LMV (clone
35βH11), CK18 (clone DC10) and CK19 (clone RCK108)
were used in a 1:100 dilution [39]. Data of mesothelial cell
experiments were gathered from four different patients.
In vitro pneumoperitoneum/experimental design
Tumour cells and similarly mesothelial cells were incubated
under three different conditions.
Experimental set 1 (pH 6.1+CO2) was performed in
Petri dishes placed inside a Perspex chamber and incubated
at a CO2 pressure of 10 mmHg and a continuous gas flow
of 2.5 l/min. The settings of CO2 pneumoperitoneum were
mimicked in vitro by an airtight Perspex chamber (26×26×
7 cm) with one influx for the application of humidified CO2
and two ports to measure gas pressure and saturation,
respectively. The pneumoperitoneum chamber was located
in an incubator set at 37°C. Prior to incubation in the
chamber, medium was equilibrated for 1 h to CO2 and pH
was adjusted to 6.1. After 0.5, 1, 2, and 5 h of incubation in
a 99.5% CO2 atmosphere, samples were harvested.
Experimental set 2 (pH 6.1) was performed in a standard
cell incubator (5% CO2 atmosphere) and again pH was
adjusted to 6.1. Under these conditions, the cells were
harvested again after 0.5, 1, 2, and 5 h of incubation.
Set 3 (pH 7.4) served as control with cells incubated in a
standard cell incubator and physiological pH of 7.4.
RNA extraction and real-time reverse transcription
polymerase chain reaction analysis
Total RNA was isolated by RNeasy Mini Kit (Qiagen,
Hilden, Germany) according to the manufacturer’s instruc-
tions and stored at −80°C.
Concentration and integrity of the total RNA were
analysed on a RNA Nano LabChip® Kit (Agilent Technol-
ogies, Waldbronn, Germany). Reverse transcription poly-
merase chain reactions (RT-PCRs) were performed with
one-step RT-PCR Kit (Qiagen, Hilden, Germany). Gene
expression was quantified using an iCycler iQ real-time
detection system (BioRad, Munich, Germany). Amplifica-
tion was performed using the following intron-spanning
primers: PAI-1 forward primer, 5′-CTG ACT TCA CGA
GTC TTT CAG ACC-3′; PAI-1 reverse primer, 5′-CCC
ATG AAA AGG ACT GTT CCT GTG-3′; uPA forward
primer 5′-AGA ATT CAC CAC CAT CGA GA-3′;u P A
reverse primer, 5′-ATC AGC TTC ACA ACA GTC AT-3′;
tPA forward primer, 5′-CAT AAG GAA TTC GAT GAT
GAC ACT TAC GAC-3′ and tPA reverse primer, 5′-GAC
TGT TCT GTT AAG TAA ATG TTG TGA TGT-3′.
For quantification, the standard curves were established
with gene-specific standard cRNA in tenfold dilution series
of 0.01 to 1,000 attomol instead of total RNA. The standard
curves were generated individually for all genes investigat-
ed, and data were calculated by iCycler iQ real-time
detection system software (BioRad).
Statistical analysis
The expression of PAI, uPA and tPA was analysed in an
ANOVA model using the statistical software package SAS
(Proc Mixed). In the analysis of tumour cell lines, all lines
Table 1 Variance analysis of PAI-1 expression (colon carcinoma cell lines HCT116, SW 48 and WiDr)
Effect p value (global) Paired comparison
a Ratio
b p values
pH 6.1 vs. ctrl. (P vs. C) Time (0 Ctrl.), 0,5, 1, 2 and 5 h incubation 0.0005
c P0.5 vs. C0 0.51 0.2791
P1 vs. C0 4.37 0.0299
P2 vs. C0 12.15 0.0013
c
P5 vs. C0 10.84 0.0018
c
pH 6.1+CO2 vs. ctrl. (P vs. C) Time (0 Ctrl.), 0,5, 1, 2 and 5 h incubation 0.0001
c G0.5 vs. C0 0.84 0.5733
G1 vs. C0 0.71 0.2725
G2 vs. C0 1.18 0.5843
G5 vs. C0 5.17 0.0001
c
aDifferent time points (P) 0.5, 1, 2 and 5 h were compared with the control (C, time 0)
bThe ratio of gene expression of the particular paired comparison
cSignificant p values after Bonferroni correction for pairwise comparisons (level α=0.0125)
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oneanalysis.Inasecondanalysis,the mesothelialcellsoffour
patients were investigated together. Two models were
investigated for both data sets: (1) experimental set 1 (pH
6.1+CO2) versus control set (pH 7.4) and (2) experimental
set 2 (pH 6.1) versus control set (pH 7.4). The time effect in
the ANOVA analysis was modelled with five levels
identifying the control with time 0 h and including four
time points for the experimental sets (0.5, 1, 2, and 5 h).
Four pairwise comparisons were performed between the
control and each time point of the experimental set using a
Bonferroni-adjusted significance level of 0.0125 (=0.05/4).
In the analysis of tumour cell lines, the PCR was
replicated twice for PAI and uPA. These two replications
were considered as a random factor nested under the fixed
factor cell line. For tPA, the PCR was not replicated, thus,
effects of the cell line and the variability produced by the
replication of the PCR could not be separated and the cell
line was modelled as a random factor. In the analysis of
mesothelial cells, the patient was analogously considered as
a random factor. All possible fixed and random interaction
terms were included in the analysis. Triplets were measured
for each PCR and time point (three readings). The ANOVA
models were based on the logarithmic expression values.
The expression ratio between two groups averaged over the
cell lines or patients was estimated by taking the exponen-
tial of the mixed model estimates for the logarithmic
differences.
Results
Mesothelial cells
Cultured cells appeared in a flat “cobblestone” pattern and
grew to a confluence of 75% of the dish surface within
1 week. Cells cultured on plastic slides were immunoreac-
tive using antibodies detecting CK8, CK18, and CK19
which are known to be characteristic for mesothelial cells
(data not shown) [39]. The cells did not reveal any staining
when using the anti-fibroblast antibody (Dianova100, clone
5B5, MO877, Glostrup, Denmark) [38].
No significant differences were found in the expression
of PAI-1, tPA and uPA between experimental set 2 (pH 6.1)
and set 1 (pH 6.1+CO2) compared to the control sets (pH
7.4; data not shown).
Colon carcinoma cell lines
PAI-1 expression increased markedly in all colon carcinoma
cell lines (HT116, SW48 and WiDr) in both experimental sets
2 (pH 6.1) and 1 (pH 6.1+CO2)w i t h i n5ho fi n c u b a t i o n
compared to the control set (pH 7.4; Fig. 1). The increase of
PAI-1 expression in experimental set 1 (pH 6.1+CO2)w a s
inhibited noticeably at every point in time compared to
experimental set 2 (pH 6.1). Insufflation with CO2 dimin-
ished the expression of PAI-1 compared to experimental set
2 (pH 6.1, without CO2).
Variance analysis of the pooled colon carcinoma cell
lines revealed significant differences (p<0.0125) in PAI-1
expression during an observation period from 2 h (p=
0.0013) to 5 h (p=0.0018) in experimental set 2 (pH 6.1)
compared to the control set (pH 7.4). There was a
significant increase in PAI-1 expression after 5 h incubation
in set 1 (pH 6.1+CO2) compared to the control set (pH 7.4)
as well (p=0.0001; Table 1). Whereas PAI-1 expression in
set 1 (pH 6.1+CO2) did not increase significantly before
5 h, the absence of CO2 resulted in a significant increase as
early as 2 h.
Moreover, uPA expression increased in experimental set
2 (pH 6.1) after 5 h incubation compared to the control set
(pH 7.4; Fig. 2). This increase was not observed in set 1.
Here, no change in uPA expression was observed compared
to the control set.
Fig. 1 The effect of pH 6.1 and pH 6.1+CO2 on RNA expression of
PAI-1 using qRT-PCR on colon carcinoma cell lines HCT116, SW48
and WiDr. PH 7.4 served as control. The data were expressed as mean±
standard error from six readings (two replications of the PCR, each with
three readings)
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significant increase in uPA expression in set 2 after 5 h (p=
0.0039; Table 2). No significant changes were observed in
set 1. Here, insufflation with CO2 inhibited the expression
of the plasmin activator uPA.
The tPA expression of the colon carcinoma cell lines in
experimental sets 1 and 2 did not exhibit any significant
differenceswhencomparedtothecontrolset(datanotshown).
Furthermore, none of the analyses demonstrated system-
atically different expression curves for the three tumour cell
lines since no interaction between time and cell line was
observed.
Discussion
For the first time, this study investigates the changes in
gene expression in the plasmin activator system of colon
carcinoma cells as well as mesothelial cells under the
conditions of CO2 pneumoperitoneum.
Interestingly, PAI-1 expression is significantly enhanced
in colon carcinoma cells when exposed to pH 6.1 and a
CO2 pressure of 10 mmHg within 5 h (Fig. 1). Without
CO2 insufflation, the increase in PAI-1 expression is always
greater. The same changes are observed for uPA expression.
Here, the lower pH enhances uPA expression significantly
compared to the control group. However, simultaneous
exposure to CO2 has no effect on uPA expression. The acid
pH seems to induce enhanced PAI-1 and uPA expression,
but additional CO2 pressure inhibits this effect (Figs. 1 and
2). Variance analysis of the tumour cell lines revealed
significant differences (p<0.0125) with respect to PAI-1
expression in the analysed groups (pH 6.1 and pH 6.1+
CO2) compared to the control group (pH 7.4) within 2 h
(Table 1). There is also a significant increase in uPA
expression (Table 2) in the same tumour cell lines under
acid conditions within a time interval of 5 h.
Therefore, it appears likely that the increase in PAI-1 and
uPA expression is caused by acid pH 6.1, a value which
matches the intraabdominal conditions during laparoscopic
surgery with CO2 insufflation [26]. The inhibition of PAI-1
and uPA expression employing CO2 is confirmed by
variance analysis. Additional experiments are warranted to
establish the molecular mechanisms of these findings. No
Fig. 2 The effect of pH 6.1 and pH 6.1+CO2 on RNA expression of
uPA using qRT-PCR on colon carcinoma cell lines HCT116, SW48 and
WiDr. PH 7.4 served as control. The data were expressed as mean±
standard error from six readings (two replications of the PCR, each with
three readings)
Table 2 Variance analysis of uPA expression (colon carcinoma cell lines HCT116, SW 48 and WiDr)
Effect p value (global) Paired comparison
a Ratio
b p values
pH 6.1 vs. ctrl. (P vs. C) Time (0 Ctrl.), 0,5, 1, 2 and 5 h incubation 0.0015
c P0.5 vs. C0 0.51 0.1772
P1 vs. C0 1.06 0.9092
P2 vs. C0 3.47 0.0213
P5 vs. C0 5.35 0.0039
c
pH 6.1+CO2 vs. ctrl. (P vs. C) Time (0 Ctrl.), 0,5, 1, 2 and 5 h incubation 0.3538 G0.5 vs. C0 0.87 0.4649
G1 vs. C0 1.27 0.2153
G2 vs. C0 1.14 0.4779
G5 vs. C0 1.10 0.6129
aDifferent time points (P) 0.5, 1, 2 and 5 h were compared with the control (C, time 0)
bThe ratio of gene expression of the particular paired comparison
csignificant p values after Bonferroni correction for pairwise comparisons (level α=0.0125)
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expression of the tested colon carcinoma cell lines in the
experimental sets 1 (pH 6.1+CO2) and 2 (pH 6.1)
compared to the control set.
In contrast to tumour cells, the expression of PAI-1, uPA,
and tPA in the mesothelial cells revealed no significant
differences when compared to the control. These results are
confirmed by a prospective randomised study by Neu-
decker et al. [8] who did not observe any significant
differences in uPA, tPA, and PAI-1 expression in peritoneal
mesenthelium during laparoscopic colon resection when
compared with conventional surgery.
PAI-1 as well as uPA is described to be an important
promoter of tumour cell invasion and metastatic spread
[40–42]. The antagonist PAI-1 protects the matrix frame-
work, which is required for tumour cell adhesion and
migration, against the proteolytic uPA [43, 44], as well as
the tumour cells themselves against excessive degradation
[45]. Similarly, the main mechanism of PAI-1 is indepen-
dent of the direct function as an inhibitor of the protease
uPA in the plasmin activator system [41, 42]. PAI-1
modulates the interaction between the uPA receptor CD87
coupled to tumour cells and vitronectin [40, 41] as well as
the connection between vitronectin and the cellular integrin
αvβ3 [42]. Therefore, tumour cell adhesion on the cellular
matrix is impaired and as a result, tumour cell migration as
well as metastatic progression is promoted [46]. Thus, our
findings of enhanced expression of PAI-1 in colon cancer
cell lines suggest an increase in the invasive potential of
colon carcinoma cells under the conditions of prolonged
laparoscopic surgery with CO2 insufflation.
Previous studies have emphasised the clear increase in
PAI expression in colon carcinoma cells compared to
unaffected epithelium [21, 23, 47, 48]. Sier et al. [48]
demonstrated a tenfold increase in PAI-1 levels and a two-
to threefold enhanced PAI-2 level for colonic adenocarci-
noma compared to normal colon epithelium. Several
authors confirmed a correlation between the level of PAI-
1 expression and the prognosis of the 3-year survival rate of
patients [17, 18]. Moreover, the PAI-1 expression correlates
with the state of differentiation and the infiltration depth of
the tumour [16].
Although randomised prospective long-term studies have
not revealed any significant survival disadvantage for patients
with colon carcinoma after laparoscopic colon carcinoma
resection in comparison with conventional surgery, optimisa-
tion of the laparoscopic conditions is still desirable from an
oncological point of view. Therefore, we hope that this study
will encourage the consideration of potential hazards in the
process of improving laparoscopic surgery.
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